Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alegro Health vs Queen RX

Alegro Health
Graded #351

Lower grade

vs+7.100000000000001
Queen RX
Graded #214

Higher grade

The verdict

Queen RX takes it — 66/100 to 58.9/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +22
54
76
Dose & formulationQueen RX +5
52
57
Clinical oversightAlegro Health +1
70
69
Labs & monitoringAlegro Health +9
62
53
FulfillmentQueen RX +18
57
75
Contract termsEven
61
61
Alegro Health · left barQueen RX · right bar

The numbers

MetricAlegro HealthQueen RX
WeighScore58.9/10066/100
GradeCC
Scorecard rank#351#214
Semaglutide$199/mo (starting dose, compounded)$100/mo (quarterly plan, compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Alegro Health

Graded #351 · C

Strengths

  • Low-cost entry point: 199 dollars for a full 8-week semaglutide starter with B12
  • Direct shipping with no recurring monthly fees
  • Operates from a physical Texas medical practice with a published phone number

Where it loses points

  • Semaglutide only; no tirzepatide offered
  • Available in select states only, which are not enumerated
  • Thin public information and compounding pharmacy not named on the site
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard